MD Medical Group IPJSC (“MD Medical”, "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, announces its operating and unaudited financial results for Q4 and 12M of 2024.

Key financial highlights for 12M 2024:

• Total revenue increased by 19.9%  y-o-y to RUB 33,122 million

• Like-for-like (LFL) revenue grew by 16.4% y-o-y

• Revenue of the Group’s hospitals in Moscow rose by 21.4% y-o-y to RUB 16,297 million primarily on the back of robust revenue growth in the segment of in-patient care, largely due to an increase in surgeries (up 13.4% y-o-y)

• Revenue of the Group’s regional hospitals grew by 18.4% y-o-y to RUB 8,896 million, driven by strong results in in-patient and out-patient treatments 

• Revenue from out-patient clinics in Moscow and the Moscow Region rose by 10.6% y-o-y to RUB 3,192 million on the back of an increase in out-patient treatments

• Revenue from out-patient clinics in other regions rose by 23.5% y-o-y to RUB 4,670 million, driven by robust growth in demand for out-patient treatments and IVF services

• As at the end of 2024, the Group’s cash position stood at RUB 6,050 million, with no debt financing raised by the Company

• Total Capex for 12M 2024 was RUB 2,273 million

Key operational highlights for 12M 2024:

• Total out-patient treatments increased by 15.0% y-o-y to 2,441,914, with the average ticket up 11.4% y-o-y to RUB 6.1 thousand in Moscow and up 11.7% y-o-y to RUB 2.5 thousand in other regions

• Total deliveries increased by 13.4% y-o-y to 11,214, with the average ticket up 17.9% y-o-y to RUB 574.5 thousand in Moscow and up 14.4% y-o-y to RUB 230.9 thousand in other regions

• Total IVF punctures went up by 3.3% y-o-y to 19,970, with the average ticket up 7.4% y-o-y to RUB 311.9 thousand in Moscow and up 10.9% y-o-y to RUB 299.4 thousand in other regions

• Total in-patient treatments increased by 1.4% y-o-y to 148,437 amid a 6.7% uptick in surgeries, with the average in-patient care ticket up 22.4% y-o-y to RUB 109.1 thousand in Moscow and up 8.0% y-o-y to RUB 42.9 thousand in other regions

Key financial highlights for Q4 2024:

• Despite the strong base effect from Q4 2023, total revenue increased by 13.8% y-o-y, reaching a quarterly record of RUB 9,089 million

• Revenue of the Group’s hospitals in Moscow rose by 10.6% y-o-y to RUB 4,417 million due to an increase in revenue from out-patient treatments, deliveries, and IVF services

• Revenue of the Group’s hospitals in regions rose by 18.4% y-o-y to RUB 2,456 million due to an increase in revenue from out-patient and in-patient treatments and deliveries

• Revenue from out-patient clinics in Moscow and the Moscow Region rose by 12.6% y-o-y to RUB 912 million mostly thanks to stronger out-patient revenue

• Revenue from out-patient clinics in other regions increased by 16.5% y-o-y to RUB 1,277 million due to growing revenue from out-patient treatments and IVF services

Key operational highlights for Q4 2024:

• Total out-patient treatments increased by 7.6% y-o-y to 648,355, with the average ticket up 16.9% y-o-y to RUB 6.4 thousand in Moscow and up 14.9% y-o-y to RUB 2.6 thousand in other regions

• Total deliveries increased by 12.3% y-o-y to 2,896, with the average ticket up 10.9% y-o-y to RUB 602.4 thousand in Moscow and up 14.1% y-o-y to RUB 238.1 thousand in other regions

• Total IVF punctures went up by 2.8% y-o-y to 5,353, with the average ticket up 6.3% y-o-y to RUB 328.1 thousand in Moscow and up 12.8% y-o-y to RUB 321.9 thousand in other regions

• Total in-patient treatments decreased by 4.9% y-o-y to 38,634 amid a 3.4% uptick in surgeries, with the average in-patient care ticket up 19.0% y-o-y to RUB 115.3 thousand in Moscow and up 8.0% y-o-y to RUB 44.8 thousand in other regions

Key events during Q4 2024 and after the reporting period:

• New clinic in Khabarovsk launch – expansion to new region. On 30 January 2025 the Group opened Mother & Child Khabarovsk clinic. Spanning 560 sq m, the facility will offer a wide range of specialised services for women in obstetrics, gynaecology, oncology, and reproductive medicine. The new clinic is designed to accommodate 30,000 visits and 800 IVF cycles per year. The cllinic has received a total investment of RUB 113 million for its opening and outfitting.

• New clinic in Krasnogorsk of Moscow region launch. On 16 January 2025 the Group opened Mother & Child Krasnogorsk clinic with a total area of 242 sq m which offers a wide range of specialized services for women. The capacity of the clinic allows for 36,000 outpatient visits per year. Total investments in the project came in at RUB 44 million.

• New clinic in the Orekhovo-Borisovo district of Moscow launch. On 17 December 2024 the Group opened the Mother & Child Orekhovo-Borisiovo clinic with a total area of 201 sq m which offers a wide range of specialized services for women. The capacity of the clinic allows for 24,000 outpatient visits per year. Total investments in the project came in at RUB 38 million.

• 9M 2024 Dividends announcement and payment.  At the meeting held on 18 November 2024, the Company’s Board of Directors decided to distribute dividends for 9M 2024 in the amount of RUB 1.5 billion, or RUB 20 per ordinary share. Dividend payments were made in December.

• New clinic in Domodedovo of Moscow region launch. On 2 November 2024 the Group opened Mother & Child Domodedovo clinic with a total area of 173 sq m which offers a wide range of specialized services for women. The capacity of the clinic allows for 24,000 outpatient visits per year. Total investments in the project came in at RUB 34 million.

• New clinic in Chelyabinsk launch – expansion to new region. On 24 October 2024 the Group opened Mother & Child Chelyabinsk clinic. Spanning 420 sq m and centrally located, the facility will offer a wide range of specialised services for women in obstetrics, gynaecology, oncology, breast health, and reproductive medicine. The new clinic is designed to accommodate 18,000 visits and 800 IVF cycles per year. The cllinic has received a total investment of RUB 105 million for its opening and outfitting.

• New medical centre in the Moscow City launch. On 9 October 2024 the Group opened the new multidisciplinary centre Lapino City, spanning 1,460 sq m, which offers a comprehensive array of out-patient medical services for adults, focusing on the diagnosis, treatment, and prevention of various diseases. These are available at two key facilities: the Diagnostic and Treatment Centre, which includes radiology and endoscopy departments, and the Women’s Health Centre – both offering day hospital care. Patients can consult with doctors from over 25 different specialities on a daily basis. The new medical centre is designed to accommodate 100,000 visits and 1,500 IVF cycles per year. Lapino City has received a total investment of RUB 372 million for its opening and outfitting.

• New clinic in the Solntsevo district of Moscow launch. On 1 October 2024 the Group opened the Mother & Child Solntsevo clinic with a total area of 175 sq m which offers a wide range of specialized services for women. The capacity of the clinic allows for 24,000 outpatient visits per year. Total investments in the project came in at RUB 33 million.

MD Medical CEO Mark Kurtser said:

Notes:
1.     Data is based on management accounts
2.     Minor variations in calculation of totals, subtotals and/or percentage change are due to rounding of decimals

***

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 65 state-of-the-art healthcare facilities, including 11 multidisciplinary hospitals and 54 out-patient clinics in 31 regions of the Russian Federation. In 2024, MD Medical Group's revenue amounted to RUB 33.1 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).